Browse 881 autoimmune disorders clinical trials enrolling across the United States and Canada. 117 people applied to autoimmune disorders studies last month. Search by city or state to find one near you.
There are more than 80 autoimmune diseases, from rheumatoid arthritis and psoriasis to lupus and multiple sclerosis, and together they affect a large share of people, most of them women. In each one, the immune system mistakenly attacks the body's own tissues. Treatment has moved from broad immune suppression to medicines that block specific immune signals, and most recently to approaches that aim to reset the immune system entirely.
Phase 2 Study of ADX-038 in Complement-Mediated Kidney Disease
for
IgAN, C3G, Complement-mediated Kidney Disease,
Location: Great Neck NY, Shelby MI, Iowa City IA, Houston TX,
Sponsor: ADARx Pharmaceuticals, Inc.
Sex: All
Age: 18+
Code: NCT06989359
Phase 2, Recruiting
A Longitudinal, Observational Study Comparing Real-World Experiences of Teplizumab-Treated and Untreated Participants With Stage 2 Type 1 Diabetes in the United States
for
Type 1 Diabetes
Location: San Francisco CA
Sponsor: Sanofi
Sex: All
Age: 8+
Code: NCT07260110
Recruiting
C-Carbs: A CGM-guided Approach to Teaching Carb Awareness
for
Type 1 Diabetes
Location: Los Angeles CA
Sponsor: University of California, Los Angeles
Sex: All
Age: 18+
Code: NCT07807280
Recruiting
A Study Comparing Effectiveness of Kesimpta® (Ofatumumab) Versus Ocrevus® (Ocrelizumab) in Real-world Practice
for
Multiple Sclerosis
Location: East Hanover NJ
Sponsor: Novartis Pharmaceuticals
Sex: All
Age: 18 - 70+
Code: NCT07779460
Recruiting
Study to Evaluate the Efficacy and Safety of Oral Rilzabrutinib in Adults With Immune Thrombocytopenia (ITP) Who Failed First-line Treatment
for
Immune Thrombocytopenia
Location: Danvers MA, Boston MA, The Bronx NY, Albany NY,
Sponsor: Sanofi
Sex: All
Age: 18+
Code: NCT07007962
Phase 3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
A Study to Investigate the Efficacy, Safety, and Pharmacokinetics of Oral Rilzabrutinib Compared With Placebo in Participants 18 Years of Age and Older With Warm Autoimmune Hemolytic Anemia
for
Autoimmune Haemolytic Anaemia
Location: Boston MA, Providence RI, New Haven CT, The Bronx NY,
Sponsor: Sanofi
Sex: All
Age: 18+
Code: NCT07086976
Phase 3, Recruiting
Phase 1b/2 Study of IV Sarilumab in Adult With RA
for
Rheumatoid Arthritis
Location: Duncansville PA, Hollywood FL, Hialeah FL,
Sponsor: Sanofi
Sex: All
Age: 18+
Code: NCT07704580
Phase 1, Phase 2, Recruiting
A Study to Investigate the Efficacy and Safety of Rilzabrutinib in Adult Participants With Graves' Disease
for
Graves' Disease
Location: Sherbrooke, Calgary, Surrey
Sponsor: Sanofi
Sex: All
Age: 18 - 70+
Code: NCT06984627
Phase 2, Recruiting
A Study to Assess Adverse Events, How the Drug Moves Through the Body and Effectiveness of Intravenous Infusions of ABBV-319 in Adult Participants With Systemic Lupus Erythematosus (SLE), Sjogren's Disease (SjD) and Rheumatoid Arthritis (RA)
for
Dry Eye Syndrome, Systemic Lupus Erythematosus
Location: Margate FL, Tampa FL, Orland Park IL, Memphis TN,
Sponsor: AbbVie
Sex: All
Age: 18 - 70+
Code: NCT06977724
Phase 1, Recruiting
A Study of Enpatoran in Participants With Cutaneous Manifestations of Lupus With or Without Systemic Disease
for
Systemic Lupus Erythematosus (SLE),
Location: Tamarac FL, Cooper City FL, Miami FL, Tampa FL, Troy MI,
Sponsor: EMD Serono Research & Development Institute, Inc.
Sex: All
Age: 18 - 70+
Code: NCT07332481
Phase 3, Recruiting
A Study to Investigate Efficacy and Safety of Teplizumab Compared With Placebo in Participants 1 to 25 Years of Age With Stage 3 Type 1 Diabetes
for
Type 1 Diabetes Mellitus
Location: Halifax, New Haven CT, New York NY, Philadelphia PA,
Sponsor: Sanofi
Sex: All
Age: 1 - 25
Code: NCT07088068
Phase 3, Recruiting
Open-label Extension Study of Zigakibart in Adults With IgA Nephropathy.
